References
- Sen S, Kannan NB, Kumar J, et al. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int Ophthalmol. 2021;11:1–14.
- Ulhaq ZS, Soraya GV. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch Clin Exp Ophthalmol. 2020;258(6):1351–1352. doi:10.1007/s00417-020-04695-8.
- Marinho PM, Marcos AAA, Romano AC, et al. Retinal findings in patients with COVID-19. Lancet. 2020;395:1610. doi:10.1016/S0140-6736(20)31014-X.
- Zago Filho LA, Lima LH, Melo GB, et al. Vitritis and outer retinal abnormalities in a patient with COVID-19. Ocul Immunol Inflamm. 2020 16;28(8):1298–1300. doi:10.1080/09273948.2020.1821898.
- Zhou L, Xu Z, Guerra J, et al. Expression of the SARS-CoV-2 receptor ACE2 in human retina and diabetes-implications for retinopathy. Invest Ophthalmol Vis Sci. 2021 Jan;62(7):6. doi:10.1167/iovs.62.7.6.